400 mg LX4211
LX4211.1-103-DDI
Phase 1 small_molecule completed
Quick answer
400 mg LX4211 for Type 2 Diabetes Mellitus is a Phase 1 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEXICON PHARMACEUTICALS, INC.
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed